Diabetes is the leading cause of chronic kidney disease due to microvascular damage to the renal blood vessels.
Read More »Diabetes and Children’s Brain Development
A recent longitudinal study examines diabetes type 1 and brain cognitive differences in children.
Read More »Don’t Be So Quick to Stop a Treatment That’s Working
Man, 52 years of age, type 2 diabetes, obesity class II on Victoza. He was very pleased with treatment response, lowering glucose levels, feeling full and more satisfied, but having a skin reaction.
Read More »ADA 81st Symposium: Treatment for Prediabetes and Diabetes Can Be Found at a Grocery Store, Part 1
A prescription for vegetables can significantly lower weight, blood pressure, and A1C.
Read More »ADA 81st Symposium: Treatment for Prediabetes and Diabetes Can Be Found at a Grocery Store, Part 2
Better food choices can lower the incidence of diabetes and kidney disease, and reduce the need for medications.
Read More »ADA 81st Symposium: A Targeted Approach of Delivering Diabetes Education Improved Health Outcomes in Vulnerable Populations
Diet and exercise coaches are the future of preventing T2D in patients with overweight or obesity.
Read More »ADA 2021: Finerenone in the Chronic Kidney Disease and Diabetes Population
Finerenone is a mineralocorticoid receptor antagonist indicated for chronic kidney disease (CKD) with type 2 diabetes. Does the use of insulin affect its performance against kidney and cardiovascular issues?
Read More »ADA 2021: Lowering of Blood Pressure and Pulse Rate by Switching from DPP-4 Inhibitor to Luseogliflozin in Patients with T2D and Hypertension
Researchers investigate the changes in ambulatory blood pressure using the antidiabetic drug in patients with type 2 diabetes and hypertension.
Read More »Can Physical Activity Improve Cognitive Function?
A meta-analysis was conducted to determine the impact of physical activity on cognition improvement in patients with diabetes.
Read More »Greater Weight Loss Found With SGLT-2 Inhibitors Than GLP-1 RAs in Patients with T2D
Contrary to previous studies, new research finds SGLT-2i more effective for weight loss than GLP-1 RAs as add-on therapy to Metformin.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.